Literature DB >> 21441610

Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization.

Jutta Walstab1, Folkert Steinhagen, Michael Brüss, Manfred Göthert, Heinz Bönisch.   

Abstract

The aim of this study was to analyze functional properties of the naturally occurring C23S variant of the human 5-HT2C receptor. In HEK293 cells transiently expressing the unedited forms of the variant receptor (VR) or the wild-type receptor (WTR), surface expression was determined by [3H]mesulergine binding to membrane fragments. Function was examined by an aequorin luminescence-based Ca2+ assay. Surface expression of the VR was 116% of that of the WTR. The 5-HT-induced increase in cytosolic Ca2+ ([Ca2+]i), and its inhibition by the inverse agonist SB 206553 did not differ between VR- or WTR-expressing cells. Preexposure of VR- or WTR-expressing cells to 0.5 μM 5-HT (3 min-4.5 h) led to a practically identical time course and extent in the reduction of the 5-HT-induced increase in [Ca2+]i. In contrast, prolonged preexposure to the inverse agonist SB 206553 (1 μM) elevated the 5-HT-induced increase in [Ca2+]i for both isoreceptors. A preexposure time of 4.5 h was necessary to significantly elevate the Ca2+ response of the WTR, but the VR produced this elevation within 1 h with virtually no further effect after 4.5 h of preexposure. In conclusion, prolonged preexposure to 5-HT caused equally rapid and strong desensitization of both isoreceptors. The different time course of SB 206553-induced resensitization of the two isoreceptors might be therapeutically relevant for drugs exhibiting inverse agonist properties at 5-HT2C receptors, such as atypical antipsychotics and certain antidepressants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441610     DOI: 10.1016/s1734-1140(11)70397-8

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  8 in total

Review 1.  The activity of the serotonin receptor 2C is regulated by alternative splicing.

Authors:  Stefan Stamm; Samuel B Gruber; Alexander G Rabchevsky; Ronald B Emeson
Journal:  Hum Genet       Date:  2017-06-29       Impact factor: 4.132

2.  Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system.

Authors:  S E Swinford-Jackson; N C Anastasio; R G Fox; S J Stutz; K A Cunningham
Journal:  Neuroscience       Date:  2016-02-27       Impact factor: 3.590

Review 3.  Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.

Authors:  Kathryn A Cunningham; Noelle C Anastasio
Journal:  Neuropharmacology       Date:  2013-07-11       Impact factor: 5.250

4.  Striatal dopamine release and genetic variation of the serotonin 2C receptor in humans.

Authors:  Brian J Mickey; Benjamin J Sanford; Tiffany M Love; Pei-Hong Shen; Colin A Hodgkinson; Christian S Stohler; David Goldman; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

Review 5.  Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.

Authors:  Leonard L Howell; Kathryn A Cunningham
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 6.  Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Authors:  H Bönisch; K B Fink; B Malinowska; G J Molderings; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-15       Impact factor: 3.000

7.  Variation within the serotonin (5-HT) 5-HT₂C receptor system aligns with vulnerability to cocaine cue reactivity.

Authors:  N C Anastasio; S Liu; L Maili; S E Swinford; S D Lane; R G Fox; S C Hamon; D A Nielsen; K A Cunningham; F G Moeller
Journal:  Transl Psychiatry       Date:  2014-03-11       Impact factor: 6.222

8.  Serotonin 5-HT2C Receptor Cys23Ser Single Nucleotide Polymorphism Associates with Receptor Function and Localization In Vitro.

Authors:  Michelle A Land; Holly L Chapman; Brionna D Davis-Reyes; Daniel E Felsing; John A Allen; F Gerard Moeller; Lisa A Elferink; Kathryn A Cunningham; Noelle C Anastasio
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.